Literature DB >> 12511849

Growth hormone binding protein. The soluble growth hormone receptor.

G Baumann1.   

Abstract

The high affinity growth hormone binding protein (GHBP), the soluble ectodomain of the growth hormone receptor (GHR), is an integral part of the growth hormone (GH)-insulin-like growth factor axis. Depending on the species, it is either a cleavage product of the GHR or a splice variant of the Ghr gene. GHR cleavage/GHBP shedding is effected by TACE (TNF-alpha converting enzyme), a metalloproteinase of the ADAM family, and possibly related enzymes. The GHBP modulates GH action through both inhibitory and enhancing mechanisms. Because of its complex in vivo effects, the biological role of the GHBP is still incompletely understood. The main clinical application of GHBP measurements is in the diagnosis of genetic growth hormone insensitivity (Laron syndrome).

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12511849

Source DB:  PubMed          Journal:  Minerva Endocrinol        ISSN: 0391-1977            Impact factor:   2.184


  16 in total

1.  The soluble leptin receptor neutralizes leptin-mediated STAT3 signalling and anorexic responses in vivo.

Authors:  Jiejin Zhang; Philip J Scarpace
Journal:  Br J Pharmacol       Date:  2009-05-06       Impact factor: 8.739

Review 2.  Healthful aging mediated by inhibition of oxidative stress.

Authors:  Stephen F Vatner; Jie Zhang; Marko Oydanich; Tolga Berkman; Rotem Naftalovich; Dorothy E Vatner
Journal:  Ageing Res Rev       Date:  2020-10-19       Impact factor: 10.895

3.  GH, IGF-I and GH receptors mRNA expression in response to growth impairment following a food deprivation period in individually housed cichlid fish Cichlasoma dimerus.

Authors:  Tomás Horacio Delgadin; Daniela Irina Pérez Sirkin; María Paula Di Yorio; Silvia Eda Arranz; Paula Gabriela Vissio
Journal:  Fish Physiol Biochem       Date:  2014-10-29       Impact factor: 2.794

Review 4.  Growth hormone resistance in uremia, a role for impaired JAK/STAT signaling.

Authors:  Ralph Rabkin; Di Fei Sun; Yu Chen; Jane Tan; Franz Schaefer
Journal:  Pediatr Nephrol       Date:  2005-02-04       Impact factor: 3.714

5.  Intermittent hypoxia suppression of growth hormone and insulin-like growth factor-I in the neonatal rat liver.

Authors:  Charles Cai; Taimur Ahmad; Gloria B Valencia; Jacob V Aranda; Jiliu Xu; Kay D Beharry
Journal:  Growth Horm IGF Res       Date:  2018-03-08       Impact factor: 2.372

Review 6.  Growth hormone - past, present and future.

Authors:  Michael B Ranke; Jan M Wit
Journal:  Nat Rev Endocrinol       Date:  2018-03-16       Impact factor: 43.330

7.  MAP dendrimer elicits antibodies for detecting rat and mouse GH-binding proteins.

Authors:  Roberto M Aguilar; Frank J Talamantes; Juan J Bustamante; Jesus Muñoz; Lisa R Treviño; Andrew O Martinez; Luis S Haro
Journal:  J Pept Sci       Date:  2009-02       Impact factor: 1.905

8.  Protein interacting with C-kinase 1/protein kinase Calpha-mediated endocytosis converts netrin-1-mediated repulsion to attraction.

Authors:  Joseph L Bartoe; William L McKenna; Tiffani K Quan; Benjamin K Stafford; Jenna A Moore; Jun Xia; Kogo Takamiya; Richard L Huganir; Lindsay Hinck
Journal:  J Neurosci       Date:  2006-03-22       Impact factor: 6.167

Review 9.  The contribution of growth hormone to mammary neoplasia.

Authors:  Jo K Perry; Kumarasamypet M Mohankumar; B Starling Emerald; Hichem C Mertani; Peter E Lobie
Journal:  J Mammary Gland Biol Neoplasia       Date:  2008-02-07       Impact factor: 2.673

10.  The effect of exercise type on immunofunctional and traditional growth hormone.

Authors:  Leslie A Consitt; Richard J Bloomer; Laurie Wideman
Journal:  Eur J Appl Physiol       Date:  2007-03-15       Impact factor: 3.346

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.